The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for STARR Life Sciences sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
STARR Life Sciences is a medical equipment company that manufactures and supplies laboratory devices. The company’s flagship product, MouseOx Plus pulse oximeter, represents the second generation of the original pulse oximeter designed for mice and rats. It also manufactures other accessories like Pulse Oximeter sensors, MouseOx Plus software, Analog Data output module and multiplexers. Its products are used by researchers and veterinarians from universities, pharmaceutical companies, and contract research organizations. STARR Life Sciences is headquartered in Oakmont, Pennsylvani, the US.
The key metrics of STARR Life Sciences related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As STARR Life Sciences is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as STARR Life Sciences.
For a detailed understanding of the performance of STARR Life Sciences, buy the report here.